Jubilant Organosys gets Canada nod for drug
Jubilant Organosys gets Canada nod for drug
Mumbai: Drug maker Jubilant Organosys Ltd said on Monday its Canada unit, Draxis, has received safety approval for generic sestamibi from Health Canada.
Sestamibi is used in the treatment of myocardial infection, ischemic heart disease and coronary artery disease, the company said in a statement.
The promoters of HT Media Ltd, which publishes Mint, and promoters of Jubilant Organosys Ltd are closely related. The companies have no promoter cross-holdings.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!